journal article·2024-08Open access

Multifunctional Dopamine‐Based Hydrogel Microneedle Electrode for Continuous Ketone Sensing

Irfani Rahmi Ausri, Sadegh Sadeghzadeh, Subhamoy Biswas, Hanjia Zheng, Peyman GhavamiNejad, Michelle Dieu Thao Huynh, Fatemeh Keyvani, Erfan Shirzadi, Fasih A Rahman, Joe Quadrilatero, Amin GhavamiNejad, Mahla Poudineh

Advanced Materials· Volume 36· Issue 32

Abstract

Abstract Diabetic ketoacidosis (DKA), a severe complication of type 1 diabetes (T1D), is triggered by production of large quantities of ketone bodies, requiring patients with T1D to constantly monitor their ketone levels. Here, a skin‐compatible hydrogel microneedle (HMN)‐continuous ketone monitoring (HMN‐CKM) device is reported. The sensing mechanism relies on the catechol–quinone chemistry inherent to the dopamine (DA) molecules that are covalently linked to the polymer structure of the HMN patch. The DA serves the dual‐purpose of acting as a redox mediator for measuring the byproduct of oxidation of 3‐beta‐hydroxybutyrate (β‐HB), the primary ketone bodies; while, also facilitating the formation of a crosslinked HMN patch. A universal approach involving pre‐oxidation and detection of the generated catechol compounds is introduced to correlate the sensor response to the β‐HB concentrations. It is further shown that real‐time tracking of a decrease in ketone levels of T1D rat model is possible using the HMN‐CKM device, in conjunction with a data‐driven machine learning model that considers potential time delays.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adipose Tissue and Metabolism · Electrochemical sensors and biosensors · Diabetes Management and Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Electrical and Computer Engineering University of Waterloo Waterloo ON N2L 3G1 Canada

Waterloo Institute for Nanotechnology University of Waterloo Waterloo ON N2L 3G1 Canada

Department of Kinesiology and Health Sciences University of Waterloo Waterloo ON N2L 3G1 Canada

Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy University of Toronto Toronto ON M5S 3M2 Canada

References (53)

Show source-provided references
1. 10.1016/j.metabol.2015.12.00710.1016/j.metabol.2015.12.007 ↗
2. 10.2337/dc09-903210.2337/dc09-9032 ↗
3. 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-810.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8 ↗
4. 10.1900/RDS.2016.13.21710.1900/RDS.2016.13.217 ↗
5. 10.1177/1932296821100986010.1177/19322968211009860 ↗
6. 10.1002/adhm.20190168310.1002/adhm.201901683 ↗
7. 10.1002/adma.20170224310.1002/adma.201702243 ↗
8. 10.1002/smll.20190591010.1002/smll.201905910 ↗
9. 10.1038/s44222-023-00108-710.1038/s44222-023-00108-7 ↗
10. 10.1038/s41551-020-00672-y10.1038/s41551-020-00672-y ↗
11. 10.1038/s41551-022-00887-110.1038/s41551-022-00887-1 ↗
12. 10.1021/acs.analchem.9b0510910.1021/acs.analchem.9b05109 ↗
13. 10.1021/acssensors.3c0267710.1021/acssensors.3c02677 ↗
14. 10.1177/1932296821100818510.1177/19322968211008185 ↗
15. 10.1021/acs.analchem.2c0082910.1021/acs.analchem.2c00829 ↗
16. 10.1016/j.bios.2023.11580210.1016/j.bios.2023.115802 ↗
17. 10.1016/j.sna.2003.12.02910.1016/j.sna.2003.12.029 ↗
18. 10.1016/B978-0-12-814944-7.00003-510.1016/B978-0-12-814944-7.00003-5 ↗
19. 10.1007/s11892-017-0857-410.1007/s11892-017-0857-4 ↗
20. 10.1016/j.bios.2004.07.00910.1016/j.bios.2004.07.009 ↗
21. 10.1021/ja00288a03510.1021/ja00288a035 ↗
22. 10.1016/j.bios.2006.02.01810.1016/j.bios.2006.02.018 ↗
23. 10.1016/j.colsurfb.2014.10.03210.1016/j.colsurfb.2014.10.032 ↗
24. 10.1016/j.snr.2021.10003210.1016/j.snr.2021.100032 ↗
25. 10.1016/j.bios.2022.11489110.1016/j.bios.2022.114891 ↗
26. 10.1016/S0302-4598(97)00042-110.1016/S0302-4598(97)00042-1 ↗
27. 10.1016/j.snb.2009.01.03010.1016/j.snb.2009.01.030 ↗
28. 10.1016/j.snb.2005.10.02710.1016/j.snb.2005.10.027 ↗
29. 10.1002/smll.20220020110.1002/smll.202200201 ↗
30. 10.1002/adhm.20220236210.1002/adhm.202202362 ↗
31. 10.1016/j.bbadis.2010.06.00610.1016/j.bbadis.2010.06.006 ↗
32. 10.1016/j.tet.2011.06.02610.1016/j.tet.2011.06.026 ↗
33. 10.1002/masy.20085141810.1002/masy.200851418 ↗
34. 10.1146/annurev.bi.60.070191.00405110.1146/annurev.bi.60.070191.004051 ↗
35. 10.1002/app.5188710.1002/app.51887 ↗
36. 10.1111/j.1755-148X.2009.00636.x10.1111/j.1755-148X.2009.00636.x ↗
37. 10.1016/j.snb.2016.01.01210.1016/j.snb.2016.01.012 ↗
38. 10.1016/j.electacta.2018.08.11310.1016/j.electacta.2018.08.113 ↗
39. 10.1016/j.trac.2023.11693810.1016/j.trac.2023.116938 ↗
40. 10.1016/j.chemosphere.2020.12804310.1016/j.chemosphere.2020.128043 ↗
41. 10.1038/s41551-018-0335-610.1038/s41551-018-0335-6 ↗
42. 10.2337/dc06-991610.2337/dc06-9916 ↗
43. 10.1016/j.device.2023.10011210.1016/j.device.2023.100112 ↗
44. 10.1126/sciadv.abi629010.1126/sciadv.abi6290 ↗
45. 10.1021/acsabm.9b0100310.1021/acsabm.9b01003 ↗
46. Wren‐Dail M. A. · Comp. Med. · 2017 · 67 · 138
47. 10.1016/S0167-9473(01)00065-210.1016/S0167-9473(01)00065-2 ↗
48. 10.1021/acs.jcim.9b0118410.1021/acs.jcim.9b01184 ↗
49. 10.1089/15209150175022004610.1089/152091501750220046 ↗
50. 10.1177/193229681455479710.1177/1932296814554797 ↗
51. 10.1016/j.bspc.2012.05.00710.1016/j.bspc.2012.05.007 ↗
52. Roe J. N. · Crit. Rev. Ther. Drug Carrier Syst. · 1998 · 15
53. 10.1007/s11892-012-0307-210.1007/s11892-012-0307-2 ↗